Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 749 across all filing types
Latest filing 2019-06-10 Regulatory Filings
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
D&O Ongoing Disclosures – Multiple
Regulatory Filings
2019-06-10 English
D&O Initial Disclosure – Chris Gallaher
Regulatory Filings
2019-06-05 English
D&O Ongoing Disclosure – John Duncan
Regulatory Filings
2019-05-30 English
Pacific Edge Reports Continued Growth in FY19
Annual Report Classification · 95% confidence The document is a company announcement dated 29 May 2019 reporting the audited financial results for the fiscal year ended 31 March 2019. It contains detailed financial performance data such as revenue, expenses, net loss, cash position, and operational highlights. It also discusses business outlook and strategic objectives for the next fiscal year. The presence of comprehensive financial results and operational commentary for a full fiscal year indicates this is an Annual Report. The document is over 11,000 characters, so it is not a brief announcement or a report publication notice. It is not a quarterly or interim report, nor is it a regulatory filing or certification. Therefore, the appropriate classification is Annual Report (10-K). FY 2019
2019-05-28 English
International Urology Experts Present on Cxbladder
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 20 May 2019 from Pacific Edge Limited. It describes an event where international urology experts presented on the clinical and commercial use of the company's diagnostic product, Cxbladder. The text includes descriptions of the product's clinical utility and benefits but does not contain any financial data, regulatory filings, or detailed financial reports. It is a promotional and informational announcement about presentations and product features rather than a formal report or regulatory filing. The document length is 4370 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication of financial results, voting results, management changes, or other regulatory disclosures. Therefore, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2019-05-20 English
Further compelling clinical evidence supporting Cxbladder
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 17 May 2019, discussing clinical evidence supporting the diagnostic performance of a product called Cxbladder. It includes detailed clinical study results, quotes from company executives and medical professionals, and references to a published paper in a clinical journal. The content focuses on clinical validation and product utility rather than financial data, regulatory compliance, or corporate governance. There is no indication that this is a financial report, earnings release, regulatory filing, or any other formal corporate filing type. The document is a public announcement of clinical study results and product information, which does not fit into any of the specific financial or corporate filing categories. Therefore, the best fit is Regulatory Filings (RNS), which serves as a fallback category for miscellaneous company announcements that do not fit other categories.
2019-05-16 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.